GLP-1s and Anesthesia Holds: The Pre-Surgery Prescription Pause Explained

GLP-1 Prescriptions Editorial Team · July 17, 2026 · 8 min read
Affiliate Disclosure: This site contains affiliate links to telehealth providers. If you click a link and make a purchase, we may receive a commission at no extra cost to you. All opinions are our own. Links marked "Paid link" are sponsored placements. See our full disclosure.

Why GLP-1s and Anesthesia Don't Mix Well

GLP-1 receptor agonists slow gastric emptying — that's part of how they help with weight loss. But during anesthesia, a full or slowly-emptying stomach creates a serious risk: pulmonary aspiration. If stomach contents reflux into the airway while you're under general anesthesia and can't protect your airway, the result can be aspiration pneumonia or worse.

This risk prompted the American Society of Anesthesiologists (ASA) to issue guidance on pre-operative GLP-1 management. The guidance applies to any procedure requiring sedation or general anesthesia, including surgeries, endoscopies, and other procedures where airway reflexes are suppressed.

Current ASA Guidance

The ASA's current recommendations for pre-operative GLP-1 management:

Weekly injectable GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic): Hold for at least 7 days before the procedure. This allows sufficient time for gastric motility to return to baseline.

Daily GLP-1s (oral semaglutide, liraglutide): Hold for at least 1 day before the procedure.

Day-of assessment: Regardless of hold duration, your anesthesiologist may perform a point-of-care gastric ultrasound on the day of surgery to assess stomach contents. If significant residual volume is found, the procedure may be delayed or modified.

These are general guidelines. Your surgical team may recommend longer hold periods based on your dose, GI symptom history, and the specific procedure. Always follow your surgical team's instructions over general guidance.

Do Not Self-Decide: Stopping your GLP-1 is a medical decision that should be coordinated between your prescriber and your surgical team. Don't skip doses without informing your prescriber, and don't ignore the surgical team's hold instructions.
Editor's Choice

Embody

Top Pick — $400 CPA

From $249/mo

Injectable semaglutide only. Compounded — not FDA-approved.

Check Eligibility →

Planning the Pause

If you have elective surgery scheduled, build the GLP-1 hold into your planning timeline:

4-6 weeks before: Inform your prescriber about the upcoming surgery. Discuss the hold timeline and plan for your last dose before the procedure.

7+ days before (weekly GLP-1s): Take your last dose at least 7 days (ideally 14 days for higher doses) before the procedure date.

During the hold: Expect some return of appetite. This is normal and temporary. Focus on the pre-surgical diet your surgical team recommends rather than trying to maintain GLP-1-level appetite suppression.

Day of surgery: Follow your anesthesiologist's fasting instructions precisely. Report your GLP-1 use and the date of your last dose to your surgical team — even if you think they already know.

Restarting After Surgery

When to restart your GLP-1 after surgery depends on the procedure type, your recovery, and your prescriber's judgment. General considerations:

For minor outpatient procedures: You can typically resume your GLP-1 at your next scheduled dose after the procedure, assuming you're eating and drinking normally.

For major surgery: Your prescriber may recommend waiting until you're tolerating oral intake consistently before resuming. If you had GI surgery, the restart timeline may be extended to ensure surgical healing isn't compromised by slowed gastric emptying.

Retitration may be needed. If your hold lasted more than 2-4 weeks, your prescriber may recommend restarting at a lower dose and retitrating to avoid GI side effects. The restart protocol follows the same guidelines as any treatment gap.

Data-Driven

Wellorithm

Science-Forward

From $199/mo

Compounded — not FDA-approved.

Check Eligibility →
Brand-Name Rx

Sesame Care

Brand-Name Marketplace

From $99/visit

FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.

Check Eligibility →
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with potential side effects including nausea, vomiting, diarrhea, and in rare cases, pancreatitis or thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a licensed healthcare provider before starting any medication. Compounded medications are not FDA-approved for safety, efficacy, or quality.